Fernando Rodriguez has devoted his scientific live to the field of vaccine development. He performed his phD thesis at CISA-INIA in Madrid, trying to characterize the most immunogenic surface proteins from African swine fever virus (ASFV). In 1996 he moved to The Scripps Institute, La Jolla, California, in 1996, where he worked as a postdoctoral fellow firsts and as associate professor later in the laboratory of Lindsay Whitton, focusing his work in developing new strategies to improve DNA vaccination. After 5 years at Scripps, Fernando moved back to Spain as principal investigator at the Hospital 12 de Octubre in Madrid, opening a research line focused on cancer immunetherapy. In the year 2003, was recruited by The Centre for research on animal health (CReSA); today being the Animal health Program of The Research Institute for Agrifood Technology  of Catalonia (IRTA). Fernando leads a Research line devoted to obtaining a vaccine against ASFV. Authors 80 per-reviewed papers, lead several Contracts with the industry, 12 competitive projects, 3 patents and has supervised 6 Doctoral Thesis. In September 2018, Fernando Rodriguez became the Scientific Director of IRTA-CReSA.